JANE RUPP: Open Payments
NPI 1265936850 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 13 payments from 9 companies in 2025. Trend: 2023 $224 · 2024 $910 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $285 |
| Novo Nordisk Inc | 3 | $60 |
| Astellas Pharma US Inc | 2 | $43 |
| Gilead Sciences, Inc. | 1 | $29 |
| Ardelyx, Inc. | 1 | $27 |
| ViiV Healthcare Company | 1 | $26 |
| Dexcom, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: FREESTYLE LIBRE 3, Veozah, IBSRELA, DOVATO, Dexcom G6 Transmitter, Rybelsus, Ozempic, GVOKE HYPOPEN.
Industry payments across OH — which companies pay providers there.
